Celastrol ameliorates ulcerative colitis by inhibiting HSP90-mediated necroptosis of intestinal epithelial cells.

Lu K, Wang Y, Shi Y, Liu S, Shao Y, Wang Z, Xu E

Open source

DOI
10.3389/fphar.2026.1866303
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1866303,
  title = {Celastrol ameliorates ulcerative colitis by inhibiting HSP90-mediated necroptosis of intestinal epithelial cells.},
  author = {Lu K and Wang Y and Shi Y and Liu S and Shao Y and Wang Z and Xu E},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1866303},
  url = {https://doi.org/10.3389/fphar.2026.1866303}
}

RIS

TY  - JOUR
TI  - Celastrol ameliorates ulcerative colitis by inhibiting HSP90-mediated necroptosis of intestinal epithelial cells.
AU  - Lu K
AU  - Wang Y
AU  - Shi Y
AU  - Liu S
AU  - Shao Y
AU  - Wang Z
AU  - Xu E
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1866303
UR  - https://doi.org/10.3389/fphar.2026.1866303
ER  - 

APA

K, L., Y, W., Y, S., S, L., Y, S., Z, W., & E, X. (2026). Celastrol ameliorates ulcerative colitis by inhibiting HSP90-mediated necroptosis of intestinal epithelial cells.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1866303

Source records